Tarsus Pharmaceuticals Ownership | Who Owns Tarsus Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Tarsus Pharmaceuticals Ownership Summary


Tarsus Pharmaceuticals is owned by 113.06% institutional investors, 8.73% insiders. Rtw investments, lp is the largest institutional shareholder, holding 9.67% of TARS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Tarsus Pharmaceuticals shares.

TARS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTarsus Pharmaceuticals113.06%8.73%-21.79%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp3.41M9.67%$92.75M
Blackrock3.27M9.25%$88.79M
Paradigm biocapital advisors lp2.44M6.90%$66.19M
Tang capital management2.25M6.39%$61.29M
Cowen and company2.20M6.22%$59.72M
Vanguard group1.99M5.64%$54.08M
Morgan stanley1.88M5.34%$51.23M
Frazier life sciences management1.59M4.50%$43.15M
Jennison associates1.48M4.19%$40.22M
Perceptive advisors1.30M3.67%$35.24M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management2.25M6.24%$61.29M
Tfg asset management gp500.00K3.39%$13.59M
Paradigm biocapital advisors lp2.44M2.53%$66.19M
Frazier life sciences management1.59M2.02%$43.15M
Ghost tree capital235.00K2.00%$6.39M
Cowen and company2.20M1.64%$59.72M
Tcg crossover management556.32K1.58%$15.12M
Sands capital ventures170.00K1.55%$4.62M
Rtw investments, lp3.41M1.44%$92.75M
Integral health asset management400.00K1.03%$10.87M

Top Buyers

HolderShares% AssetsChange
Assenagon asset management1.06M0.06%1.06M
Blackrock3.27M0.00%614.03K
Exoduspoint capital management, lp670.46K0.12%454.50K
Integral health asset management400.00K1.03%400.00K
Lord, abbett463.24K0.04%381.01K

Top Sellers

HolderShares% AssetsChange
Cormorant asset management, lp500.00K0.79%-1.64M
Vivo capital---565.55K
Morgan stanley1.88M0.00%-514.23K
Healthcare of ontario pension plan trust fund389.60K0.03%-508.40K
Paradigm biocapital advisors lp2.44M2.53%-427.99K

New Positions

HolderShares% AssetsChangeValue
Assenagon asset management1.06M0.06%1.06M$28.90M
Integral health asset management400.00K1.03%400.00K$10.87M
Caption management160.00K0.07%160.00K$4.35M
Prudential financial79.52K0.00%79.52K$2.16M
Silverarc capital management40.00K0.26%40.00K$1.09M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-5.00
Riggs asset managment-10.00
Allworth financial lp-21.00
Innealta capital-41.00
Steward partners investment advisory-59.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241689.80%43,393,9218.30%1130.88%962.13%442.33%
Jun 30, 2024153-6.71%40,069,3292.31%1130.92%94-9.62%4334.38%
Mar 31, 202416435.54%39,163,54421.70%1100.92%10438.67%3228.00%
Dec 31, 202312111.01%32,180,4918.01%1091.16%75-2592.31%
Sep 30, 202310914.74%29,793,10638.99%971.52%7519.05%13-7.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.14M2.98%1.86K
iShares Russell 2000 ETF945.73K2.49%-2.13K
PGIM Jennison Small Company A664.86K1.74%185.97K
MEDICAL BioHealth EUR Acc628.24K1.65%354.25K
Vanguard Institutional Extnd Mkt Idx Tr527.70K1.38%-1.62K
Invesco Small Cap Value A484.80K1.27%-
Jennison SMid Cap Core Equity478.89K1.26%124.60K
Jennison Health Sciences Equity457.94K1.20%209.09K
Artisan Non-U.S. Small-Mid Growth Comp457.19K1.20%64.35K
Artisan International Small-Mid Investor457.19K1.20%64.35K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 12, 2024LINK WILLIAM J PHD-Sell$133.21K
Aug 12, 2024LINK WILLIAM J PHD-Sell$779.75K
Jun 18, 2024Farrow Jeffrey S See RemarksSell$286.92K
Mar 18, 2024Mottiwala Aziz Chief Commercial OfficerSell$145.84K
Mar 18, 2024Wahl Bryan General CounselSell$135.74K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3-2
2024 Q2-1
2024 Q1-5
2023 Q4111

TARS Ownership FAQ


Who Owns Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals shareholders are primarily institutional investors at 113.06%, followed by 8.73% insiders and -21.79% retail investors. The average institutional ownership in Tarsus Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Tarsus Pharmaceuticals exceeds.

Who owns the most shares of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals’s largest shareholders are Rtw investments, lp (3.41M shares, 9.67%), Blackrock (3.27M shares, 9.25%), and Paradigm biocapital advisors lp (2.44M shares, 6.90%). Together, they hold 25.82% of Tarsus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Tarsus Pharmaceuticals?

Yes, BlackRock owns 9.25% of Tarsus Pharmaceuticals, totaling 3.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 88.79M$. In the last quarter, BlackRock increased its holdings by 614.03K shares, a 23.15% change.

Who is Tarsus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Tarsus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.24% of its assets in 2.25M Tarsus Pharmaceuticals shares, valued at 61.29M$.

Who is the top mutual fund holder of Tarsus Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tarsus Pharmaceuticals shares, with 2.98% of its total shares outstanding invested in 1.14M Tarsus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools